Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility

Science (Impact Factor: 33.61). 07/2014; 345(6193). DOI: 10.1126/science.1253533


Circulating tumor cells (CTCs) are present at low concentrations in the peripheral blood of patients with solid tumors. It has been proposed that the isolation, ex vivo culture, and characterization of CTCs may provide an opportunity to noninvasively monitor the changing patterns of drug susceptibility in individual patients as their tumors acquire new mutations. In a proof-of-concept study, we established CTC cultures from six patients with estrogen receptor-positive breast cancer. Three of five CTC lines tested were tumorigenic in mice. Genome sequencing of the CTC lines revealed preexisting mutations in the PIK3CA gene and newly acquired mutations in the estrogen receptor gene (ESR1), PIK3CA gene, and fibroblast growth factor receptor gene (FGFR2), among others. Drug sensitivity testing of CTC lines with multiple mutations revealed potential new therapeutic targets. With optimization of CTC culture conditions, this strategy may help identify the best therapies for individual cancer patients over the course of their disease.

Download full-text


Available from: Nicola Aceto, Jul 23, 2014
309 Reads
  • Nature reviews. Cancer 07/2014; 14(9). DOI:10.1038/nrc3799 · 37.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The type of collision between the European and the Adriatic plates in the easternmost Alps is one the most interesting questions regarding the Alpine evolution. Tectonic processes such as compression, escape and uplift are interconnected and shape this area. We can understand these ongoing processes better, if we look for signs of the deformation within the Earth's deep crust of the region. By collecting records from permanent and temporary seismic networks, we assemble a receiver function dataset, and analyze it with the aim of giving new insights on the structure of the lower crust and of the shallow portion of the upper mantle, which are inaccessible to direct observation. Imaging is accomplished by performing common conversion depth stacks along three profiles that crosscut the Eastern Alpine orogen, and allow isolating features consistently persistent in the area. The study shows a moderately flat Moho underlying a seismically anisotropic middle-lower crust from the Southern Alps to the Austroalpine nappes. The spatial progression of anisotropic axes reflects the orientation of the relative motion and of the stress field detected at the surface. These observations suggest that distributed deformation is due to the effect of the Alpine indentation. In the shallow upper mantle right below the Moho interface, a further anisotropic layer is recognized, extended from the Bohemian Massif to the Northern Calcareous Alps.
    Journal of Geodynamics 08/2014; DOI:10.1016/j.jog.2014.07.005 · 2.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Circulating tumor cells (CTCs) are cancer cells that break away from either a primary tumor or a metastatic site and circulate in the peripheral blood as the cellular origin of metastasis. With their role as a “tumor liquid biopsy”, CTCs provide convenient access to all disease sites, including that of the primary tumor and the site of fatal metastases. It is conceivable that detecting and analyzing CTCs will provide insightful information in assessing the disease status without the flaws and limitations encountered in performing conventional tumor biopsies. However, identifying CTCs in patient blood samples is technically challenging due to the extremely low abundance of CTCs among a large number of hematologic cells. To address this unmet need, there have been significant research endeavors, especially in the fields of chemistry, materials science, and bioengineering, devoted to developing CTC detection, isolation, and characterization technologies.
    Accounts of Chemical Research 08/2014; DOI:10.1021/ar5001617 · 22.32 Impact Factor
Show more